心血管腎臓代謝症候群のエビデンスベースの管理への実施障壁

Gina Davis¹, Dana Kim², Min Jun³

¹Department of Nephrology, Prince of Wales Hospital, Sydney, NSW, Australia.

Heart, lung & circulation

|August 27, 2025

まとめ

心血管・腎臓・代謝症候群 (CKM) は世界的な健康問題であり治療へのアクセスを改善する必要があります CKM療法の低普及は,システム,提供者,患者の障壁に起因し,多学科ケアへの移行が必要である.

科学分野:

心臓病科
腎臓科
内分泌学
公衆衛生

背景:

心血管・腎臓・代謝症候群 (CKM) は,心血管疾患,腎臓疾患,肥満,および2型糖尿病を結びつける新しい状態である.
CKM症候群は,世界的な罹病率と死亡率の主な原因であり,かなりの医療費がかかります.
CKM症候群の個人に不均衡な影響を及ぼしている.

研究の目的:

CKM症候群の最適な管理を妨げている課題と障壁を強調する.
CKM症候群に対する医療アプローチのパラダイムシフトの必要性を強調する.

主な方法:

CKM症候群の病理生理学,危険因子,治療結果に関する現在の証拠のレビュー
システム,提供者,患者要因を含むCKM治療への障壁の分析.
公衆衛生政策と臨床実践への影響について議論する.

主要な成果:

心臓腎臓代謝療法 (例えばSGLT2阻害剤,GLP- 1RA,MRA) の有効性が証明されているにもかかわらず,その摂取量は低いままです.
重要なシステム障壁 (政策,分散したケア,アクセス),提供者障壁 (認識,惰性),患者障壁 (社会的決定因子) は,最適なCKMケアを妨げています.
CKM症候群は,特にオーストラリアでは,かなりの経済的負担が伴う.

結論:

CKM症候群の治療には多面的で多学科的なアプローチが不可欠です
高リスクの患者グループに薬剤療法への公平なアクセスが不可欠です
この公衆衛生上の緊急事態に対処し,CKM症候群のアウトカムを改善するには,緊急の世界的な行動が必要です.

キーワード:

心血管疾患心血管 - 腎臓 - 代謝症候群慢性腎臓疾患メタボリックシンドローム健康の社会的決定因子

さらに関連する動画

06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K

09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.8K

関連する概念動画

01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

505

01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

01:22

Heart Failure Drugs: Diuretics

483

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

483

関連する実験動画